Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 894 participants.
Also called NCT01912677
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 894 participants
- Registry
-
NCT01912677
-
- Other papers using this trial's data
- Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01912677. Randomized; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
- Condition
- Hypertension in Pregnancy
- Condition
- Preeclampsia
- Intervention (Drug)
- Nifedipine
- Intervention (Drug)
- Labetalol
- Intervention (Drug)
- Methyldopa
- Lead sponsor
- Gynuity Health Projects
- Collaborator
- Government Medical College, Nagpur
- Collaborator
- Daga Memorial Women's Hospital, Nagpur, India
- Collaborator
- University of British Columbia
- Collaborator
- Bill and Melinda Gates Foundation
Record details
- Record id
cardio:ct-nct01912677- Content hash
0c9015819fd5105ca9db40911b10e3e739c9d85fee716c707d7a0d2835b79ede